![Richard Wagner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Wagner
Fondateur chez
Bonito Biosciences
Profil
Richard W.
Wagner was the founder of X-Chem, Inc. (Massachusetts), founded in 2009, serving as Chief Executive Officer from 2009 to 2020.
Dr. Wagner is the founder of Bonito Biosciences, Inc., founded in 2019, serving as Chief Executive Officer & Director.
Dr. Wagner was the founder of Zebiai Therapeutics, Inc., founded in 2019, serving as Chief Executive Officer.
Dr. Wagner is also the founder of X Rx, Inc...
Dr. Wagner was an Independent Director at Ernexa Therapeutics, Inc. in 2023.
Dr. Wagner was Executive Vice President-Discovery Research at Praecis Pharmaceuticals, Inc. Dr. Wagner earned a doctorate from Brown University.
Dr. Wagner completed undergraduate studies at Trinity College (Connecticut).
Postes actifs de Richard Wagner
| Sociétés | Poste | Début |
|---|---|---|
Bonito Biosciences
 Bonito Biosciences Packaged SoftwareTechnology Services Provides AI based drug target services | Fondateur | - |
Anciens postes connus de Richard Wagner
| Sociétés | Poste | Fin |
|---|---|---|
| ERNEXA THERAPEUTICS INC. | Directeur/Membre du Conseil | 08/08/2023 |
X-Chem, Inc. (Massachusetts)
 X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services Provides DNA-encoded library-based drug discovery technology services | Directeur Général | 03/06/2020 |
X Rx, Inc.
 X Rx, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule medicines in inflammation, fibrosis and oncology | Fondateur | - |
Zebiai Therapeutics, Inc.
 Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets | Directeur Général | - |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies for the treatment of cancer | Directeur Technique/Scientifique/R&D | - |
Formation de Richard Wagner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies for the treatment of cancer | Health Technology |
X Rx, Inc.
X Rx, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule medicines in inflammation, fibrosis and oncology | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity College (Connecticut)
 Trinity College (Connecticut) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services Provides DNA-encoded library-based drug discovery technology services | Technology Services |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets | Technology Services |
Eterna Therapeutics, Inc.
 Eterna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Bonito Biosciences
Bonito Biosciences Packaged SoftwareTechnology Services Provides AI based drug target services | Technology Services |
